Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

NUT Carcinoma Treatment Team

  • For a rare and aggressive disease such as NUT carcinoma, experience matters. At Dana-Farber/Harvard Cancer Center (DF/HCC), our team of experienced NUT carcinoma specialists works together to provide patients with expert, compassionate, and comprehensive care.

    Adult Patients

    Geoffrey Shapiro, MD, PhD
    Geoffrey Shapiro, MD, PhD
    • Dana-Farber Cancer Institute Physician
    • Center for Cancer Therapeutic Innovation
    • Clinical Director, Center for DNA Damage and Repair
    • Professor of Medicine, Harvard Medical School

    Dr. Shapiro specializes in clinical trials for adult patients with NUT carcinoma.


    Jia Luo, MD
    Jia Luo, MD
    • Dana-Farber Cancer Institute Physician
    • Thoracic Oncology Program
    • Instructor in Medicine, Harvard Medical School

    Dr. Luo specializes in both standard of care and clinical trial options for adults with NUT carcinoma that originated, or is primarily located, in the lung or thoracic/chest cavity.


    Glenn Hanna, MD
    Glenn J. Hanna, MD
    • Dana-Farber Cancer Institute Physician
    • Head and Neck Cancer Center
    • Assistant Professor of Medicine, Harvard Medical School

    Dr. Hanna specializes in both standard of care and clinical trial options for adult patients with NUT carcinoma that originated, or is primarily located, in the head and neck region.


    Pediatric Patients

    Steven DuBois, MD, MS
    Steven DuBois, MD, MS
    • Dana-Farber Cancer Institute Physician
    • Director, Experimental Therapeutics
    • Senior Physician
    • Associate Professor of Pediatrics, Harvard Medical School

    Dr. DuBois specializes in both standard of care and clinical trial options for pediatric patients with NUT carcinoma.


    Pathology

    Christopher French, MD
    Christopher A. French, MD
    • Associate Professor, Pathology, Harvard Medical School
    • Associate Professor, Pathology, Brigham and Women's Hospital

    Our clinical team works closely with Brigham and Women's Hospital pathologist Christopher French, MD, who oversees the International NUT Midline Carcinoma Registry. Dr. French played a pivotal role in the discovery of the NUT fusion oncogene. As a pathologist, Dr. French does not see patients; however, he is a leader in the field and is involved in much of the research surrounding NUT carcinoma. Dr. French is available for pathology consultation to assist referring physicians with diagnosis.


  • Thoracic Oncology Program

    Simone Becker, BSN, RN
    Research Nurse

    Stefania Molinaro, BS
    Clinical Research Coordinator


    NUT Registry and Research, Thoracic Oncology Program

    Elinton Lee, BA
    Research Data Specialist

    Michelle Sanchez, BS
    Research Data Specialist